Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 139, Issue 5, Pages (November 2010)

Similar presentations


Presentation on theme: "Volume 139, Issue 5, Pages (November 2010)"— Presentation transcript:

1 Volume 139, Issue 5, Pages 1612-1618 (November 2010)
Ribavirin Therapy Inhibits Viral Replication on Patients With Chronic Hepatitis E Virus Infection  Nassim Kamar, Lionel Rostaing, Florence Abravanel, Cyril Garrouste, Sebastien Lhomme, Laure Esposito, Grégoire Basse, Olivier Cointault, David Ribes, Marie Béatrice Nogier, Laurent Alric, Jean Marie Peron, Jacques Izopet  Gastroenterology  Volume 139, Issue 5, Pages (November 2010) DOI: /j.gastro Copyright © 2010 AGA Institute Terms and Conditions

2 Figure 1 Serum hepatitis E virus RNA concentrations before and during the study period. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions

3 Figure 2 Liver enzyme levels during the study period. ALT, alanine aminotransferase; AST, aspartate aminotransferase; γGT, γ–glutamyl transpeptidase. P values are derived from comparisons of liver enzyme levels of all 6 patients using the Friedman test for repeated measurements. Normal ranges for ALT levels are 5–34 U/L; normal ranges for ALT levels are 3–30 U/L; normal ranges for γGT levels are 7–38 U/L. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions

4 Figure 3 Hemoglobin levels during ribavirin therapy. Red bold line corresponds to median values. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions


Download ppt "Volume 139, Issue 5, Pages (November 2010)"

Similar presentations


Ads by Google